First Rounders: Christoph Lengauer

Christoph Lengauer is a venture partner at Third Rock Ventures, the president of Celsius Therapeutics, and executive vice president at Blueprint Medicines. His conversation with Nature Biotechnology covers growing up in Austria, why he nearly gave up research for a career helping settle refugees, and his role in the Henrietta Lacks story.

Hosted on Acast. See acast.com/privacy for more information.

More from First Rounders

  1. 04:28Good ByeMay 04, 2022
  2. 01:11:46Jay KeaslingApr 01, 2022
  3. 01:03:22Ingmar HoerrFeb 01, 2022
  4. 52:17Lita NelsenDec 01, 2021
  5. 33:47Hope Lies in Dreams Chapter 1Sep 08, 2021
  6. 01:06:05Anthony AtalaSep 01, 2021
  7. 01:07:45Nancy SimonianJul 01, 2021
  8. 01:05:11Carl JuneJun 01, 2021
  9. 01:12:02Craig MelloMay 01, 2021
  10. 01:01:04Neil KumarMar 01, 2021